Skip to content
Review

The potential of vitamins in Huntington’s disease: bridging mechanistic evidence with translational limitations and future strategies

Aug 2026 · Metabolic brain disease · Vol 41 · 0 citations · 129 references
Medicine

TL;DR

How the vitamins’ potential is at stake to reach the clinical perspective is highlighted, along with different strategies to overcome their limitations using novel drug delivery and biomarker-based approaches.

View source

Similar papers

Review Open access Sep 2026

The ketogenic diet in Parkinson’s disease: mechanisms, evidence, and clinical practice

This review systematically elaborates the potential molecular mechanisms through which KD protects against PD, which covers the improvement of cerebral energy metabolism, antioxidant and anti-apoptotic activities, suppression of neuroinflammation, regulation of α-synuclein pathological aggregation, and modulation of gu...

Mula A, Yan Bai, Yu-Lin Wang et al. · 0 citations
Review Sep 2026

Designing Multi-functional Antioxidants for Neurodegenerative Disorders.

This review critically examines OS-mediated mechanisms underlying major NDs and emphasizes the therapeutic potential of designed multi-functional antioxidants as next-generation neuroprotective agents.

Kuleshwar Sahu, Rakesh Sahu, Mahima Mishra et al. · 0 citations
Review Aug 2026

Targeting Klotho Signaling for Neuroprotection in Huntington's Disease: A Comprehensive Review.

Klotho is a promising neurochemical modulator with disease-modifying properties in HD, and its multifunctional protective activities are consistent with important pathological markers of HD, necessitating more preclinical and clinical studies to confirm its translational value.

Shikha Singh, Avnesh Kumar, Falguni Goel et al. · 0 citations
Review Open access Aug 2026

Neurodegenaration: Overview

This review summarizes the major causes of neurodegeneration, recent developments in advanced cell-based in vitro models, and commonly employed neuroprotective assays, highlighting their importance in the discovery of novel therapeutic agents for neurodegenerative diseases.

D. A. Helen Sheeba, J. R, J. K et al. · 0 citations
Review Open access Aug 2026

Oxidative stress and inflammation in neurodegenerative disorders

Several promising epidemiological trials linked high dietary intake of vitamins C and E to a reduced risk of Parkinson’s disease, and plant-derived antioxidants such as polyphenols were explored for their ability to combat neuroinflammation and reduce cognitive decline.

K. Jomová, S. Alomar, Richard Valko et al. · 0 citations
Review Open access Sep 2026

The Role of Curcumin in Neurogenesis and Neuroprotection in Alzheimer’s disease: From Molecular Mechanisms to Clinical Evidence

This review discusses multi-target neuroprotective mechanisms of curcumin, critically reviews the preclinical success and human clinical trial outcomes, and highlights advanced nano formulations (solid lipid nanoparticles, colloidal sub-micron dispersions, polymeric nanoparticles, multi-walled carbon nanotubes and exos...

V. S, Sarupruthiya M, Jeevitha D et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.